NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
1-Year Est. Return 35.61%
This Quarter Est. Return
1 Year Est. Return
+35.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.4M
AUM Growth
-$59.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$9.4M
2
+$9.17M
3
+$6.61M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$5.87M
5
SLNO icon
Soleno Therapeutics
SLNO
+$5.69M

Sector Composition

1 Healthcare 99.82%
2 Materials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRM icon
26
Mirum Pharmaceuticals
MIRM
$3.67B
– –
-146,765
MRUS icon
27
Merus
MRUS
$7.16B
– –
-120,038
PTGX icon
28
Protagonist Therapeutics
PTGX
$4.77B
– –
-121,400
SLNO icon
29
Soleno Therapeutics
SLNO
$3.48B
– –
-79,650
TRML icon
30
Tourmaline Bio
TRML
$1.23B
– –
-227,090
VRNA
31
DELISTED
Verona Pharma
VRNA
– –
-147,990
XENE icon
32
Xenon Pharmaceuticals
XENE
$3.35B
– –
-158,605
ZLAB icon
33
Zai Lab
ZLAB
$3.2B
– –
-253,675
EXEL icon
34
Exelixis
EXEL
$9.3B
– –
-64,200
CLYM
35
Climb Bio
CLYM
$157M
– –
-463,654
1
2